首页> 外国专利> FREQUENCY REQUIREMENTS FOR THE PURPOSE OF BENSOTIAZINONDERIVAT MED CA-ANTAGONISKTISK NETWORK.

FREQUENCY REQUIREMENTS FOR THE PURPOSE OF BENSOTIAZINONDERIVAT MED CA-ANTAGONISKTISK NETWORK.

机译:苯并噻嗪酮衍生物医学的CA-ANTAGONISKTISK网络的频率要求。

摘要

Benzothiazine derivatives of the formula I IMAGE (I) with (R(1), R(1)', R(1)'', R(4) and R(4)' equal to hydrogen, alkyl, alkoxy, halogen, nitro, hydroxyl, acetamido or amino; R(2) equal to hydrogen, alkyl, alkenyl, phenyl; R(3) equal to hydrogen, alkyl, alkenyl, phenyl; R(5) equal to hydrogen or (C1-C3)-alkyl; R(6) equal to one of the following groups, IMAGE IMAGE with R(7) and R(8) equal to hydrogen, alkyl, cycloalkyl, phenyl; R(9) equal to hydrogen, alkyl, phenyl, pyridyl, pyrimidinyl or benzoyl; R(10) equal to hydrogen, alkyl, phenyl; R(11) equal to hydrogen, hydroxyl, alkoxy or, together with R(12), a bond; and R(12) equal to hydrogen or, together with R(11), a bond; m equal to 1, 2, 3 or 4; n equal to 0 or 1; p equal to 0, 1, 2, 3 or 4, and X equal to oxygen or two hydrogen atoms, and salts of the compounds of the formula I with physiologically tolerated acids and a process for the preparation of compounds I, likewise a method of treatment of disturbances of the calcium balance of a human body are described.
机译:具有(R(1),R(1)',R(1)'',R(4)和R(4)'的式I (I)苯并噻嗪衍生物等于氢,烷基,烷氧基,卤素,硝基,羟基,对乙酰氨基或氨基; R(2)等于氢,烷基,烯基,苯基; R(3)等于氢,烷基,烯基,苯基; R(5)等于氢或(C1-C3烷基; R(6)等于以下基团之一, ,其中R(7)和R(8)等于氢,烷基,环烷基,苯基; R(9)等于氢,烷基,苯基,吡啶基,嘧啶基或苯甲酰基; R(10)等于氢,烷基,苯基; R(11)等于氢,羟基,烷氧基或与R(12)一起形成键;和R(12)等于氢或与R(11)一起形成一个键; m等于1、2、3或4; n等于0或1; p等于0、1、2、3或4,X等于氧或两个氢原子,以及式I化合物与生理上可耐受的酸的盐以及化合物I的制备方法,同样是一种治疗ca紊乱的方法描述了人体的钙平衡。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号